Technical Analysis for KZR - Kezar Life Sciences, Inc.

Grade Last Price % Change Price Change
grade F 4.87 0.83% 0.04
KZR closed up 0.83 percent on Friday, August 16, 2019, on 42 percent of normal volume.
0 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Very Strong Down Down Up
See historical KZR trend table...

Date Alert Name Type % Chg
1,2,3 Retracement Bearish Bearish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Outside Day Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
1,2,3 Retracement Bearish Bearish Swing Setup 0.83%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.83%
Narrow Range Bar Range Contraction 0.83%
NR7 Range Contraction 0.83%
Inside Day Range Contraction 0.83%
Wide Bands Range Expansion 0.83%

Older signals for KZR ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Analyze My Stocks!
Configure default chart indicators
Basic chart:
Profile
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer.
Biotechnology Cancer Life Sciences Pharmaceutical Companies
Is KZR a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Aug 14 It’s not just Bloom Energy: Half of last year’s Bay Area IPO stocks are underwater
Aug 7 Kezar Life Sciences EPS beats by $0.02
Aug 7 Kezar Life Sciences Reports Second Quarter 2019 Financial Results and Provides Business Update
Aug 6 The Daily Biotech Pulse: Sanofi's Dupixent Found Effective For Pediatric Itchy Skin, Novavax Gets Nod For Late-Stage Study, Allakos Offering
Jul 29 Benzinga's Top Upgrades, Downgrades For July 29, 2019
Jul 5 The Daily Biotech Pulse: FDA Approves Karyopharm's Blood Cancer Treatment, Grifols' Immunodeficiency Drug; ESMO, ISTH Conferences In The Spotlight
Jul 5 Kezar Life Sciences files to sell securities
Jul 3 Shareholder Rights Law Firm Johnson Fistel Launches Investigations
Jun 27 The Daily Biotech Pulse: Verrica Rallies, Aclaris Flunked Hair Loss Study, 3 Biotechs To IPO
Jun 25 The Daily Biotech Pulse: Genfit NASH Drug In China, Conatus Explores Sale, Gilead Stitches Up Immuno-Oncology Partnership
See more KZR news...
Indicators
Indicator Value
52 Week High 36.33
52 Week Low 4.12
Average Volume 83,453
200-Day Moving Average 17.1922
50-Day Moving Average 6.6744
20-Day Moving Average 5.193
10-Day Moving Average 4.662
Average True Range 0.5443
ADX 50.43
+DI 12.7815
-DI 25.1181
Chandelier Exit (Long, 3 ATRs ) 4.8871
Chandelier Exit (Short, 3 ATRs ) 5.7529
Upper Bollinger Band 6.3441
Lower Bollinger Band 4.0419
Percent B (%b) 0.36
BandWidth 44.332756
MACD Line -0.6847
MACD Signal Line -0.8123
MACD Histogram 0.1276
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.64
Resistance 3 (R3) 5.64 5.38 5.51
Resistance 2 (R2) 5.38 5.19 5.38 5.47
Resistance 1 (R1) 5.13 5.07 5.26 5.13 5.43
Pivot Point 4.87 4.87 4.93 4.87 4.87
Support 1 (S1) 4.61 4.67 4.74 4.61 4.31
Support 2 (S2) 4.35 4.55 4.35 4.27
Support 3 (S3) 4.10 4.35 4.23
Support 4 (S4) 4.10